Highlander Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-100
| Closed | -$87.8K | – | 972 |
|
|
2023
Q4 | $87.8K | Hold |
100
| – | – | 0.03% | 313 |
|
|
2023
Q3 | $82K | Hold |
100
| – | – | 0.03% | 301 |
|
|
2023
Q2 | $72K | Hold |
100
| – | – | 0.03% | 274 |
|
|
2023
Q1 | $82K | Hold |
100
| – | – | 0.04% | 257 |
|
|
2022
Q4 | $72K | Hold |
100
| – | – | 0.04% | 253 |
|
|
2022
Q3 | $69K | Sell |
100
-100
| -50% | -$69K | 0.04% | 245 |
|
|
2022
Q2 | $118K | Hold |
200
| – | – | 0.06% | 194 |
|
|
2022
Q1 | $140K | Buy |
200
+50
| +33% | +$35K | 0.07% | 180 |
|
|
2021
Q4 | $95K | Hold |
150
| – | – | 0.04% | 218 |
|
|
2021
Q3 | $91K | Hold |
150
| – | – | 0.05% | 220 |
|
|
2021
Q2 | $84K | Hold |
150
| – | – | 0.04% | 233 |
|
|
2021
Q1 | $71K | Hold |
150
| – | – | 0.04% | 245 |
|
|
2020
Q4 | $72K | Buy |
150
+100
| +200% | +$48K | 0.04% | 234 |
|
|
2020
Q3 | $28K | Hold |
50
| – | – | 0.02% | 358 |
|
|
2020
Q2 | $31K | Hold |
50
| – | – | 0.02% | 340 |
|
|
2020
Q1 | $24K | Hold |
50
| – | – | 0.02% | 375 |
|
|
2019
Q4 | $19K | Hold |
50
| – | – | 0.01% | 440 |
|
|
2019
Q3 | $14K | Hold |
50
| – | – | 0.01% | 490 |
|
|
2019
Q2 | $16K | Hold |
50
| – | – | 0.01% | 492 |
|
|
2019
Q1 | $21K | Hold |
50
| – | – | 0.01% | 453 |
|
|
2018
Q4 | $19K | Hold |
50
| – | – | 0.01% | 460 |
|
|
2018
Q3 | $20K | Hold |
50
| – | – | 0.01% | 500 |
|
|
2018
Q2 | $17K | Hold |
50
| – | – | 0.01% | 535 |
|
|
2018
Q1 | $16K | Hold |
50
| – | – | 0.01% | 530 |
|
|
2017
Q4 | $19K | Sell |
50
-150
| -75% | -$57K | 0.01% | 508 |
|
|
2017
Q3 | $89K | Hold |
200
| – | – | 0.07% | 269 |
|
|
2017
Q2 | $98K | Buy |
+200
| New | +$98K | 0.08% | 258 |
|